Viewing Study NCT01364051


Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2026-01-04 @ 6:35 PM
Study NCT ID: NCT01364051
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-10
First Post: 2011-05-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Melanoma View
None Refractory Malignant Solid Neoplasm View
None Stage IV Cutaneous Melanoma AJCC v6 and v7 View
None Unresectable Malignant Solid Neoplasm View
Keywords: